Website Search
ID 15041
Getting the diagnosis of chronic myeloid leukemia, Bud
Description:
Interviewee: Bud.
Bud recounts receiving the diagnosis that he had chronic myeloid leukemia.
(DNAi Location: Applications > Genes and medicine > Drug design > Bud's Story > "A death sentence")
Transcript:
It was devastating there I didn't know what to do, you know, that's a death sentence. Was then. It was a death sentence. They gave me two or three years is what he gave me and that was eight years ago. I've been into it five now out of eight. So I beat it by five so far but of course that's, you know what it is, Gleevec™ there has helped me out.
Keywords:
chronic myeloid leukemia,location applications,gleevec,dnai,romine,death sentence,cml,interviewee,leukemia,bud,genes,diagnosis,medicine
This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.Related content:
- 15042. The first day of clinical trials for Gleevec, Bud and Yvonne
- Yvonne, Bud's wife, talks about the first day of the clinical trials in June of 1998.
- SOURCE: DNAi
- 15043. Bloodcount returns to normal with Gleevec, Bud and Yvonne
- CML causes an increased production of white blood cells. Bud and Yvonne talk about the breakthrough that brought Bud's white blood cell count back to normal.
- SOURCE: DNAi
- 16105. The magic pills, Bud and Yvonne
- Yvonne talks about the magic pills Bud took.
- SOURCE: DNAi
- 15057. Before and after Gleevec, Brian Druker
- Brian Druker talks about the drug he developed as a turning point in the war on cancer.
- SOURCE: DNAi
- 15712. Bud and Yvonne
- Bud and Yvonne are delighted by Bud's recovery thanks to Gleevec
- SOURCE: DNAi
- 15054. Restoring hope with Gleevec, Brian Druker
- Brian Druker talks about how Gleevec has restored patients' hope for the future.
- SOURCE: DNAi
- 15525. How Gleevec works to alleviate symptoms of myeloid leukemia, 3D animation with basic narration
- View the animation to find out how the drug Gleevec⢠inhibits the molecular cause of chronic myeloid leukemia.
- SOURCE: DNAi
- 15056. Approval for Gleevec in record time, Brian Druker
- Brian Druker credits the drug company Novartis with recognizing the importance of Gleevec and accelerating the development and approval process.
- SOURCE: DNAi
- 15082. Shutting down cancer with Gleevec, Brian Druker
- Brian Druker reflects on the importance of understanding the causes of cancer for developing new treatments.
- SOURCE: DNAi
- 15055. Using DNA science to control CML, Brian Druker
- Brian Druker talks about how the drug he designed targets the molecular cause of CML.
- SOURCE: DNAi
